Go to the list of all blogs
Allana's Avatar
published in Blogs
Oct 22, 2018
What Happened to ICOs?

What Happened to ICOs?

Initial Coin Offerings (ICOs) were all the rage in 2017. The fundraising method rocketed to prominence during the cryptocurrency boom as companies embraced the ability to raise capital without relinquishing control over operations and decision-making. The no-VC/no publicly traded approach paid immediate dividends, with crypto news source Coindesk estimating $5 billion raised via ICO in 2017, often with little more than a buzzword-heavy whitepaper and spiffy website.

Those days, however, seem to be firmly in the past. With increased press coverage came increased scrutiny – including from federal officials, who expressed concerned that the lax regulatory climate around virtual currencies enabled companies to engage in less-than-honest behavior, like raising money for a company that does not exist.

Their concerns were founded. Fraudulent ICOs were not uncommon, leaving research-averse investors (who were maybe a little too high on the idea of instant riches) fleeced – and angry. A degree of caution seems to have set in, with CoinSpeaker’s recent ICO analysis detailing the most recent declines in ICO value: a drop from $1.747 billion raised in May to $617 million as of August 19.

While fraud may have been a factor, the overall downturn in crypto markets from boom time has played a more significant role. CoinMarketCap calculates that the $800 billion market of January 2018 is now down to $200 billion – a market correction of serious proportions. Coupled with a quick failure rate for companies who offer an ICO (a study from Boston College found that 44 percent of 2,390 companies managed to still be in business after their investment round) and regulatory clampdowns and the space is much less of a Wild West environment than before.

The environment around ICOs is changing, but they aren’t dead yet. The climate in 2017 and early 2018 was ultimately unsustainable – market and behavioral corrections are natural. Caution may reign with investors, but Crunchbase detailed numerous bright spots: Hedera Hashgraph, who are “developing distributed ledger technology based on cryptographic hashgraphs, which some say are faster and have higher throughput than blockchains” raised a $100 million ICO in August after an $18 million venture capital round in March; gaming companies like CryptoKitties are blazing a new, exciting trail using “non fungible tokens” built on blockchain to “enable the creation of unique assets that can be collected and traded.”

For now, a mix of ICOs and venture capital money appears set to dominate the funding game. But if the past year has taught crypto enthusiasts anything, it’s that markets and moods can shift rapidly – traditional VC rounds may be in vogue today, but solidified markets and regulations could mean a boon for ICOs tomorrow.
 

Unsure of What Cryptocurrencies to Buy and Sell, and When to Buy and Sell Them? Ask A.I.

Tickeron has developed Artificial Intelligence capable of spotting patterns and trends in the cryptocurrency markets, and the A.I. can deliver trade ideas straight to your inbox. When the A.I. confirms a bullish or bearish pattern, it will alert users to the pattern and provide a target price for where it thinks the cryptocurrency is headed. Users can use the A.I. to track just about any cryptocurrency of your choice.

You can learn more and even start a 45-day free trial today. Get started on tickeron.com.  

Related Ticker: BTC.X

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


BTC.X sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for BTC.X moved above the 200-day moving average on September 08, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 03, 2026. You may want to consider a long position or call options on BTC.X as a result. In 42 of 145 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 29%.

Following a +2.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where BTC.X advanced for three days, in 124 of 424 cases, the price rose further within the following month. The odds of a continued upward trend are 29%.

The Aroon Indicator entered an Uptrend today. In 113 of 380 cases where BTC.X Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 30%.

Bearish Trend Analysis

The 10-day RSI Indicator for BTC.X moved out of overbought territory on October 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 11 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 25%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 24 of 92 cases where BTC.X's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 26%.

The Moving Average Convergence Divergence Histogram (MACD) for BTC.X turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 66 similar instances when the indicator turned negative. In 16 of the 66 cases the stock turned lower in the days that followed. This puts the odds of success at 24%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BTC.X declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 30%.

BTC.X broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Market Cap

The average market capitalization across the group is 1.72T. The market cap for tickers in the group ranges from 1.72T to 1.72T. BTC.X holds the highest valuation in this group at 1.72T. The lowest valued company is BTC.X at 1.72T.

High and low price notable news

The average weekly price growth across all stocks in the group was 3%. For the same group, the average monthly price growth was 7%, and the average quarterly price growth was 21%. BTC.X experienced the highest price growth at 3%, while BTC.X experienced the biggest fall at 3%.

Volume

The average weekly volume growth across all stocks in the group was -29%. For the same stocks of the group, the average monthly volume growth was 63% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating:
P/E Growth Rating:
Price Growth Rating:
SMR Rating:
Profit Risk Rating:
Seasonality Score: (-100 ... +100)
View a ticker or compare two or three
BTC.X
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.
I've always appreciated how Mastercard (MA) maintains a commanding position in the global payments industry, processing transactions across 3.4 billion cards at 150 million merchant locations worldwide. The network effects here create a formidable moat—increased adoption by issuers, acquirers, and consumers just reinforces its dominance. What stands out to me is how Mastercard is evolving beyond a pure processor into a services-first platform. Value-added services (VAS)—covering cybersecurity, data analytics, and consulting—are now approaching 40% of revenues and growing at double the rate of traditional payments.
MU shares are declining approximately -6.00% in premarket trading on April 2, 2026, pulling back to roughly $353.70 from the prior session's close of $376.27. The primary catalyst is a sweeping new round of tariff announcements from the Trump administration, dubbed by markets as "Liberation Day 2.0," which has sparked a broad risk-off selloff across technology and semiconductor stocks
Shares of Robinhood Markets are down approximately 6.15% in Thursday's intraday session, trading around $65.80 after closing at $70.11 on April 1, 2026. Wolfe Research delivered a sharp blow by cutting its price target on HOOD by 30%, citing persistent weakness in crypto trading volumes as a core drag on revenue.
What Happened to ICOs?